Skip to main content

“I am a Canadian, free to speak without fear, free to worship in my own way, free to stand for what I think right, free to oppose what I believe wrong, or free to choose those who shall govern my country. This heritage of freedom I pledge to uphold for myself and all mankind.” ~~ John G. Diefenbaker

FRASER INSTITUTE -- Canada’s comparatively weak intellectual property protections limit access to life-saving drugs


Because Canada’s protection of intellectual property in the life sciences—including biology and biochemistry—lags behind other industrialized countries, Canadian patient access to potentially life-saving biologic medicines is comparatively limited, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.

 

“Cutting-edge biologic drugs are treating previously untreatable conditions, often with fewer adverse effects, improving the health of patients and saving lives worldwide,” said Kristina Acri, associate professor of economics at Colorado College, senior fellow at the Fraser Institute and author of Biologics and Biosimilars: A Primer.

 

According to the study, as of December 2018 (the latest month of comparable data), Canada has approved only 10 “biosimilars,” which are versions of biologic drugs, compared to 15 in the United States, 20 in Australia and 62 in the European Union.

 

Biologic drugs are produced from (or contain elements of) living organisms. They are more complicated—and more expensive—to develop, produce, distribute and dispense than other medicines.

 

Subsequently, the ability of drug companies to protect their intellectual property—for example, through data exclusivity, which essentially prevents competing firms from producing generic versions of the drugs for a period of time—is essential for incentivizing the development of biologics, particularly because biopharmaceutical innovations are easily copied and sold by competitors.

 

Unfortunately, Canada’s current intellectual property laws are weak compared to laws in other jurisdictions including the U.S. and EU. For example, Canada has one of the shortest terms of data exclusivity for pre-clinical and clinical trials.

 

“If Canadian policymakers want to improve access to state-of-the-art drugs in Canada, they must strengthen protections for intellectual property,” Acri said.

Labels:

Comments

Post a Comment

Popular posts from this blog

GORDON F. D. WILSON: When The Trick Masquerades as The Treat

Thirty-seven years ago, Halloween 1987, I became the leader of the BC Liberal Party.   British Columbia was badly polarized. Social Credit held one side and the NDP the other. It had been twelve years, 1975, since Liberal MLAs Garde Gardom, Pat McGeer, and Alan Williams had walked away from their party to join Social Credit, one year after the lone Progressive Conservative MLA Hugh Curtis had abandoned his party to sit with Bill Bennett, the son and heir apparent to long-serving BC Premier, WAC Bennett.   An unwritten agreement by the biggest Canadian political shareholders, the federal Liberals and Conservatives, decided that if British Columbia was to remain a lucrative franchise from a revenue perspective, they couldn’t risk splitting the electoral vote and electing the real enemy, the NDP, so no resources would be used to finance either a Liberal or Conservative party provincially.   “There are two sides to every street,” I was told by a very prominent Canadian businessman who cont
Post a Comment
Read more

FORSETH: As a BC Conservative member, and campaign worker, I will again state that the fact these errors were found -- AND brought to light BY Elections BC -- shows the system IS working

Sadly, two and a half weeks after the BC provincial election campaign, those who want to undermine our political process are still at.  PLUS, we also have one who doesn’t even live in our country, never mind our province. I speak of the buffoon running for President of the United States, who has poisoned the well when it comes to faith in the electoral process. Just today alone, comments such as the following, were being made of posts that I shared online: ... all the votes they keep finding has just favoured NDP on in all critical ridings and soon they will flip another riding in favour of NDP, Come on. ... Elections BC has ridiculed British Columbians, and I no longer have confidence or trust in their process and competence regarding the results Then there are others online, with comments like these – who are claiming fraud in the October 19th election: ... Who is the oversight for Elections BC? They should be investigated for election fraud! ... Fraudulent election ... should be red
Post a Comment
Read more

“With the talent and dedication of this caucus we will hold David Eby to account for his government’s out of control spending and ongoing failures in healthcare, public safety and addictions" — John Rustad

Today, John Rustad, Leader of the Conservative Party of British Columbia, proudly unveiled his shadow cabinet, a dynamic team of talented individuals ready to hold David Eby’s disastrous government accountable and present a strong alternative vision for British Columbia. “ Our shadow cabinet is a diverse and experienced group, committed to restoring prosperity, public safety, and affordability for every British Columbian ,” said Rustad. “ With experts in every field, we are focused on delivering real solutions for the challenges our province faces .” Rustad emphasized the historic appointment of Aaliya Warbus as House Leader. The shadow cabinet reflects the Conservative Party’s vision to build a brighter future for British Columbia. The appointments are as follows: Leadership Positions : Aaliya Warbus – House Leader Bruce Banman – Whip Sheldon Claire – Deputy Whip Portfolios : Tony Luck – Municipal Affairs and Local Government Sharon Hartwell – Rural Communities and Rural Development I
Post a Comment
Read more

Labels

Show more